Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 12, 2021

SELL
$24.31 - $33.6 $160,421 - $221,726
-6,599 Closed
0 $0
Q2 2021

Aug 12, 2021

SELL
$26.09 - $40.4 $31,308 - $48,480
-1,200 Reduced 15.39%
6,599 $223,000
Q1 2021

May 13, 2021

BUY
$33.06 - $56.93 $257,834 - $443,997
7,799 New
7,799 $298,000
Q4 2020

Feb 09, 2021

SELL
$39.09 - $57.4 $185,677 - $272,650
-4,750 Closed
0 $0
Q3 2020

Nov 06, 2020

BUY
$28.43 - $44.67 $135,042 - $212,182
4,750 New
4,750 $206,000
Q2 2020

Aug 12, 2020

SELL
$11.71 - $30.29 $125,355 - $324,254
-10,705 Closed
0 $0
Q1 2020

May 11, 2020

BUY
$7.64 - $27.5 $81,786 - $294,387
10,705 New
10,705 $146,000
Q4 2018

Feb 14, 2019

SELL
$9.26 - $16.38 $119,917 - $212,121
-12,950 Closed
0 $0
Q3 2018

Nov 13, 2018

SELL
$7.54 - $18.31 $1.18 Million - $2.86 Million
-156,035 Reduced 92.34%
12,950 $217,000
Q2 2018

Aug 13, 2018

BUY
$4.87 - $8.42 $183,355 - $317,013
37,650 Added 28.67%
168,985 $1.24 Million
Q1 2018

May 15, 2018

BUY
$4.69 - $10.05 $367,986 - $788,543
78,462 Added 148.4%
131,335 $616,000
Q4 2017

Feb 14, 2018

SELL
$7.86 - $9.99 $70,740 - $89,910
-9,000 Reduced 14.55%
52,873 $480,000
Q3 2017

Nov 13, 2017

BUY
$8.89 - $10.4 $550,050 - $643,479
61,873
61,873 $580,000

Others Institutions Holding NVTA

About Invitae Corp


  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track Blair William & CO Portfolio

Follow Blair William & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Blair William & CO, based on Form 13F filings with the SEC.

News

Stay updated on Blair William & CO with notifications on news.